X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Orchid Chemicals with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs TEVA PHARMA (Israel) - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ORCHID PHARMA LTD   TEVA PHARMA
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
TEVA PHARMA
Dec-13
ORCHID PHARMA LTD/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1942,832-   
Low Rs352,460-   
Sales per share (Unadj.) Rs276.51,625.1-  
Earnings per share (Unadj.) Rs-79.2101.5-  
Cash flow per share (Unadj.) Rs-43.5232.9-  
Dividends per share (Unadj.) Rs088.87-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs53.91,805.2-  
Shares outstanding (eoy) m70.45848.00-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.41.6 25.4%   
Avg P/E ratio x-1.426.1 -5.5%  
P/CF ratio (eoy) x-2.611.4 -23.2%  
Price / Book Value ratio x2.11.5 144.8%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m8,0672,243,604 0.4%   
No. of employees `0002.844.9 6.2%   
Total wages/salary Rs m2,5270-   
Avg. sales/employee Rs Th6,956.130,662.0 22.7%   
Avg. wages/employee Rs Th902.50-   
Avg. net profit/employee Rs Th-1,993.01,915.4 -104.0%   
INCOME DATA
Net Sales Rs m19,4771,378,102 1.4%  
Other income Rs m4070-   
Total revenues Rs m19,8841,378,102 1.4%   
Gross profit Rs m1,103377,394 0.3%  
Depreciation Rs m2,519111,393 2.3%   
Interest Rs m5,22727,068 19.3%   
Profit before tax Rs m-6,236238,932 -2.6%   
Minority Interest Rs m201,085 1.8%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m511-156,846 -0.3%   
Tax Rs m-125-2,917 4.3%   
Profit after tax Rs m-5,58086,089 -6.5%  
Gross profit margin %5.727.4 20.7%  
Effective tax rate %2.0-1.2 -164.4%   
Net profit margin %-28.76.2 -458.6%  
BALANCE SHEET DATA
Current assets Rs m11,014930,765 1.2%   
Current liabilities Rs m32,060811,706 3.9%   
Net working cap to sales %-108.18.6 -1,250.7%  
Current ratio x0.31.1 30.0%  
Inventory Days Days9591 104.5%  
Debtors Days Days3496 35.0%  
Net fixed assets Rs m29,440450,118 6.5%   
Share capital Rs m7053,392 20.8%   
"Free" reserves Rs m2,0430-   
Net worth Rs m3,8001,530,810 0.2%   
Long term debt Rs m9,018704,654 1.3%   
Total assets Rs m46,5103,149,404 1.5%  
Interest coverage x-0.29.8 -2.0%   
Debt to equity ratio x2.40.5 515.6%  
Sales to assets ratio x0.40.4 95.7%   
Return on assets %-0.83.6 -21.2%  
Return on equity %-146.95.6 -2,611.3%  
Return on capital %-3.74.9 -75.7%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Net fx Rs m1,8650-   
CASH FLOW
From Operations Rs m1,682219,598 0.8%  
From Investments Rs m-9,860-77,812 12.7%  
From Financial Activity Rs m6,644-263,423 -2.5%  
Net Cashflow Rs m-1,535-121,637 1.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 67.84 Rs / USD

Compare ORCHID PHARMA LTD With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare ORCHID PHARMA LTD With: STERLING BIOTECH  PIRAMAL ENTERPRISES  GSK PHARMA  STRIDES SHASUN LTD  UNICHEM LAB  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jun 22, 2018 03:37 PM

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - ALEMBIC LTD COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS